Showing 1 - 2 results of 2 for search 'Dimitry Ofengeim', query time: 0.03s Refine Results
  1. 1
    Comparative CNS Pharmacology of the Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib Versus Other BTK Inhibitor Candidates for Treating Multiple Sclerosis

    Comparative CNS Pharmacology of the Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib Versus Other BTK Inhibitor Candidates for Treating Multiple Sclerosis by Timothy J. Turner, Pricilla Brun, Ross C. Gruber, Dimitry Ofengeim

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Safety, pharmacokinetics, and target engagement of a brain penetrant RIPK1 inhibitor, SAR443820 (DNL788), in healthy adult participants

    Safety, pharmacokinetics, and target engagement of a brain penetrant RIPK1 inhibitor, SAR443820 (DNL788), in healthy adult participants by Agnes Hincelin‐Mery, Xavier Nicolas, Cathy Cantalloube, Robert Pomponio, Pascale Lewanczyk, Myriam Benamor, Dimitry Ofengeim, Emmanuel Krupka, Jennifer Hsiao‐Nakamoto, Amy Eastenson, Nazem Atassi

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: